The current financial score of Prestige Consumer Healthcare Inc is 8.65. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 265.71M, representing a year-over-year increase of 6.48%, while its net profit experienced a year-over-year increase of 38.53%.
The current valuation score of Prestige Consumer Healthcare Inc is 8.27. Its current P/E ratio is 11.45, which is 81.15% below the recent high of 20.74 and 508.49% above the recent low of -46.77.
The current earnings forecast score of Prestige Consumer Healthcare Inc is 8.00. The average price target is 67.25, with a high of 75.00 and a low of 55.00.
The current price momentum score of Prestige Consumer Healthcare Inc is 4.31. Currently, the stock price is trading between the resistance level at 50.98 and the support level at 41.92, making it suitable for range-bound swing trading.
The current institutional shareholding score of Prestige Consumer Healthcare Inc is 10.00. The latest institutional shareholding proportion is 121.63%, representing a quarter-over-quarter increase of 8.20%. The largest institutional shareholder is John Rogers, holding a total of 4.87M shares, representing 2.29% of shares outstanding, with 16.05% decrease in holdings.
The current risk assessment score of Prestige Consumer Healthcare Inc is 7.73. The company's beta value is 0.37. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.